Awakn partnered with Orphan Insight Ltd., which provides consulting on bringing novel drug therapies to market. The post Awakn Advances AUD Treatment...
With only a few weeks left in the year, concern was rising over why MAPS PBC hadn’t yet submitted its NDA. All that, however, was put...
MAPS Public Benefit Corporation (“MAPS PBC”), a clinical-stage company dedicated to changing the way mental health conditions are treated, announced...
The FDA has 60 days to decide if the application will be accepted for review. The post MAPS Submits New Drug Application to FDA for MDMA...
Historic filing marks first New Drug Application submission for any psychedelic-assisted therapy. The post Breaking News: MAPS Files New Drug Application...
Historic filing marks first New Drug Application submission for any psychedelic-assisted therapy. The post Breaking News: MAPS Files New Drug Application...
Cody Shandraw is a managing partner at Ambria Capital and Co-Founder of Healing REIT, both of which are working to provide better solutions to healthcare....
It is that time again when financial reports from the previous quarter start coming out. These documents let us know which companies are moving in a...
Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi”), a licensed Canadian drug researcher and formulator specializing in controlled...
This year's Wonderland Conference in Miami provided inspiring and sometimes hilarious insights into the integration process of psychedelics entering mainstream...